Theme · live manifest · live theme JSON
MedTech Long '25 : US Drug Dev Outsourcing
8 tickers · $16.23B total market cap
Group: MedTech Long
This basket benefits from a structural shift toward U.S.-based drug development and biopharma supply chain reshoring, catalyzed by Trump 2.0's trade war posture, RFK's anti-China HHS stance, and increasing executive/federal aversion to China-based CRO/CDMO services. Even without the BIOSECURE Act passing, the regulatory and reputational risk of relying on offshore services has spurred U.S.-focused demand, contract wins, and capital investment across the domestic life sciences value chain.
MedTech Long '25 : US Drug Dev Outsourcing tracks 8 publicly listed stocks in this theme: AVTR, CDMO, CERT, CRL, CYRX, FTRE, NOTV, TKNO. See the constituent table for details.
Thesis update: 2025-04-14
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International, Inc.CRL | 05/07/2026 (BMO) | 05/07/2026 (BMO) | 3.60% | -2.26% | 10.65% | -14.18% | $7.34B | 12.5000 |
Avantor, Inc.AVTR | 04/29/2026 (BMO) | 04/29/2026 (BMO) | -18.10% | 3.05% | -14.00% | -5.68% | $5.22B | 12.5000 |
Fortrea Holdings Inc.FTRE | 05/05/2026 (BMO) | 05/05/2026 (BMO) | 3.68% | 27.67% | 14.27% | -12.34% | $1.30B | 12.5000 |
Avid Bioservices, Inc.CDMO | 12/10/2024 (BMO) | — | -0.33% | — | 2.13% | — | $798.9M | 12.5000 |
Certara, Inc.CERT | 05/11/2026 (AMC) | 05/11/2026 (AMC) | 4.12% | -19.33% | -27.54% | -9.82% | $714.0M | 12.5000 |
Cryoport, Inc.CYRX | 05/04/2026 (AMC) | 05/04/2026 (AMC) | -1.53% | 17.78% | 22.13% | 6.89% | $656.7M | 12.5000 |
Alpha Teknova, Inc.TKNO | 05/06/2026 (AMC) | 05/06/2026 (AMC) | 13.16% | 6.95% | 41.09% | -7.00% | $199.4M | 12.5000 |
Inotiv, Inc.NOTV | 05/11/2026 (AMC) | 05/11/2026 (AMC) | -13.09% | -18.81% | -6.50% | 5.71% | $9.0M | 12.5000 |
| Average | -1.06% | 2.15% | 5.28% | -5.20% | $2.03B | 12.5000 | ||
| Median | 1.64% | 3.05% | 6.39% | -7.00% | $756.5M | 12.5000 | ||
| Std Dev | 9.41% | 16.21% | 20.23% | 7.76% | $2.54B | 0.0% | ||
| Min | -18.10% | -19.33% | -27.54% | -14.18% | $9.0M | 12.5000 | ||
| Max | 13.16% | 27.67% | 41.09% | 6.89% | $7.34B | 12.5000 | ||
| % Positive Tickers | 50.00% | 57.14% | 62.50% | 28.57% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.